{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:13Z","timestamp":1787026573181,"version":"build-2736575974"},"reference-count":223,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Mature B-cell neoplasms constitute a biologically and clinically heterogeneous group of hematologic malignancies, defined by the clonal proliferation and accumulation of monotypic mature B lymphocytes, which may involve the peripheral blood, bone marrow (BM), lymphoid tissues, or present primarily in extranodal sites. While the pathogenesis of common subtypes, such as chronic lymphocytic leukemia, multiple myeloma, Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma has been extensively studied, those of rare entities like Hairy Cell Leukemia (HCL) remains poorly understood. HCL is a distinct B-cell neoplasm marked by BM infiltration of atypical \u201chairy\u201d cells, pancytopenia, BM fibrosis, and the BRAF V600E mutation, which is a defining molecular hallmark of the classic form of the disease. Analogous to solid tumors, growing evidence shows that the tumor microenvironment (TME) is a pivotal contributor in both the initiation and progression of all these malignancies. However, in rare mature B-cell neoplasms, understanding how tumor cells interact with their microenvironment, in terms of immune invasion, stromal crosstalk, and tissue remodeling, remains a challenge, partly due to the scarcity of patient samples and limited availability of preclinical models. In the context of TME, extracellular vesicles (EVs) have emerged as central mediators of intercellular communication within both solid and hematological malignancies. In line with numerous findings from solid tumors, EVs are receiving heightened attention as key mediators of disease progression, immune modulation, and treatment response in blood tumors, by modulating cellular interactions and delivering bioactive cargo in the tumor milieu. This review presents HCL within the broader spectrum of mature B-cell neoplasms, highlighting the current state of knowledge on the dynamic crosstalk between malignant B cells and their TME. Particular attention is given to EVs, which play key immuno-regulatory roles by interacting with both immune and non-immune components of the TME, including stromal cells. We explore how EVs contribute to disease pathogenesis, offering a unifying framework for integrating complex interactions that are often under-investigated in rare disease contexts. Building on this synthesis, we propose that the insights gained from well-characterized lymphoproliferative disorders may serve as a valuable foundation for investigating related yet poorly understood conditions, such as HCL. Furthermore, given the scarcity of both biological samples and reliable preclinical models for rare hematological malignancies, we highlight the strategic role of European biobanks in providing access to well-annotated clinical samples\u2014an essential resource for fostering interdisciplinary collaboration and enabling advanced experimental modelling.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1741794","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:33:13Z","timestamp":1771392793000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Understanding hairy cell leukemia in the context of mature B\u2212cell neoplasms: tumor microenvironment and extracellular vesicle contribution to disease pathogenesis"],"prefix":"10.3389","volume":"17","author":[{"given":"Vincenzo","family":"Ingangi","sequence":"first","affiliation":[{"name":"Preclinical Models of Tumor Progression Unit- Istituto Nazionale Tumori-IRCCS- Fondazione G. Pascale","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominga","family":"Amoroso","sequence":"additional","affiliation":[{"name":"Preclinical Models of Tumor Progression Unit- Istituto Nazionale Tumori-IRCCS- Fondazione G. Pascale","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Passaro","sequence":"additional","affiliation":[{"name":"Experimental Pharmacology Unit, Istituto Nazionale Tumori \u2013IRCCS\u2013 Fondazione G. Pascale","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Vaia","sequence":"additional","affiliation":[{"name":"Preclinical Models of Tumor Progression Unit- Istituto Nazionale Tumori-IRCCS- Fondazione G. Pascale","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Maltoni","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Institute of Hematology \u201cL. e A. Ser\u00e0gnoli\u201d","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Narimanfar","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University of Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Minopoli","sequence":"additional","affiliation":[{"name":"Preclinical Models of Tumor Progression Unit- Istituto Nazionale Tumori-IRCCS- Fondazione G. Pascale","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Rosa","sequence":"additional","affiliation":[{"name":"Experimental Pharmacology Unit, Istituto Nazionale Tumori \u2013IRCCS\u2013 Fondazione G. Pascale","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariateresa","family":"Ametrano","sequence":"additional","affiliation":[{"name":"Preclinical Models of Tumor Progression Unit- Istituto Nazionale Tumori-IRCCS- Fondazione G. Pascale","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Di Gennaro","sequence":"additional","affiliation":[{"name":"Experimental Pharmacology Unit, Istituto Nazionale Tumori \u2013IRCCS\u2013 Fondazione G. Pascale","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Broccoli","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Institute of Hematology \u201cL. e A. Ser\u00e0gnoli\u201d","place":["Bologna, Italy"]},{"name":"Department of Medical and Surgical Sciences, University of Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Institute of Hematology \u201cL. e A. Ser\u00e0gnoli\u201d","place":["Bologna, Italy"]},{"name":"Department of Medical and Surgical Sciences, University of Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Catani","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Institute of Hematology \u201cL. e A. Ser\u00e0gnoli\u201d","place":["Bologna, Italy"]},{"name":"Department of Medical and Surgical Sciences, University of Bologna","place":["Bologna, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Ciardiello","sequence":"additional","affiliation":[{"name":"Preclinical Models of Tumor Progression Unit- Istituto Nazionale Tumori-IRCCS- Fondazione G. Pascale","place":["Naples, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034819","article-title":"Epidemiology and etiology of leukemia and lymphoma","volume":"10","author":"Bispo","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s43556-023-00141-3","article-title":"Extranodal lymphoma: pathogenesis, diagnosis and treatment","volume":"4","author":"Yang","year":"2023","journal-title":"Mol BioMed"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023021786","article-title":"A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas","volume":"144","author":"de Leval","year":"2024","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s1052-5149(03)00039-x","article-title":"Hodgkin and non-Hodgkin lymphoma of the head and neck: clinical, pathologic, and imaging evaluation","volume":"13","author":"Weber","year":"2003","journal-title":"Neuroimaging Clin N Am"},{"key":"B5","unstructured":"Chronic lymphocytic leukemia with variant genetics\n          \n          \n            \n              Montague\n              AM\n            \n            \n              Pathak\n              S\n            \n          \n          36251840\n          Treasure Island (FL\n          StatPearls Publishing\n          StatPearls\n          \n          2025"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V13.7.609.609","article-title":"Leukemic reticuloendotheliosis","volume":"13","author":"Bouroncle","year":"1958","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2004.01.001","article-title":"Pathogenesis of myeloma bone disease","volume":"32","author":"Roodman","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.11.3909","article-title":"The non-hodgkin\u2019s lymphoma classification project","volume":"89","year":"1997","journal-title":"Blood"},{"key":"B10","first-page":"45","volume-title":"Histological and cytological typing of neoplastic diseases of hematopoietic and lymphoid tissues","author":"Math\u00e9","year":"1976"},{"key":"B11","volume-title":"Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues","author":"Jaffe","year":"2001"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the world health organization classification of hematolymphoid tumors: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"B16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s43046-022-00154-z","article-title":"Genomic landscape of mature B-cell non-Hodgkin lymphomas - an appraisal from lymphomagenesis to drug resistance","volume":"34","author":"Panda","year":"2022","journal-title":"J Egypt Natl Canc Inst"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034843","article-title":"Non-hodgkin lymphomas: Malignancies arising from mature B cells","volume":"11","author":"Shingleton","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid Malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2020.100236","article-title":"A population-based study of hairy cell leukemia over a period of 20 years","volume":"25","author":"Wiber","year":"2020","journal-title":"Cancer Treat Res Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"B21","unstructured":"Hairy cell leukemia\n          \n          \n            \n              Janus\n              A\n            \n            \n              Robak\n              T\n            \n          \n          \n            \n              Li\n              W\n            \n          \n          Brisbane (AU\n          Exon Publications\n          Leukemia\n          \n          2022"},{"key":"B22","unstructured":"Histology, B-cell lymphocyte\n          \n          \n            \n              Althwaiqeb\n              SA\n            \n            \n              Fakoya\n              AO\n            \n            \n              Bordoni\n              B\n            \n          \n          32809740\n          Treasure Island (FL\n          StatPearls Publishing\n          StatPearls\n          \n          2025"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2007.1.210","article-title":"The biology of the germinal center","volume":"2007","author":"Natkunam","year":"2007","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-120419-022408","article-title":"Germinal centers","volume":"40","author":"Victora","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-023-01962-5","article-title":"Correction: \u201cThe 5th edition of the world health organization classification of hematolymphoid tumors: lymphoid neoplasms\u201d Leukemia. 2022 jul;36(7):1720-1748","volume":"37","author":"Alaggio","year":"2023","journal-title":"Leukemia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1515\/medgen-2024-2005","article-title":"Genetic alterations in mature B- and T-cell lymphomas - a practical guide to WHO-HAEM5","volume":"36","author":"L\u00f3pez","year":"2024","journal-title":"Med Genet"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.220194","article-title":"IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study","volume":"105","author":"Rotbain","year":"2020","journal-title":"Hematologica"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-225326","article-title":"The microenvironment in mature B-cell Malignancies: a target for new treatment strategies","volume":"114","author":"Burger","year":"2009","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30029-8","article-title":"An international prognostic index for patients with chronic lymphocytic leukemia (CLL-IPI): a meta-analysis of individual patient data","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.annonc.2020.09.019","article-title":"Chronic lymphocytic leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Eichhorst","year":"2021","journal-title":"Ann Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1124360","article-title":"Molecular classification and therapeutics in diffuse large B-cell lymphoma","volume":"10","author":"Shimkus","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/hematology.2019000011","article-title":"Molecular profiling and management of mantle cell lymphoma","volume":"2019","author":"Ruan","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-07-418434","article-title":"BRAF V600E mutation in hairy cell leukemia: from bench to bedside","volume":"128","author":"Falini","year":"2016","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/srep21252","article-title":"Potential role of AKT\/mTOR signaling proteins in hairy cell leukemia: association with BRAF\/ERK activation and clinical outcome","volume":"6","author":"Lakiotaki","year":"2016","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2432062","article-title":"Cell therapy for a rare disease- hairy cell leukemia variant","volume":"13","author":"Fritz","year":"2024","journal-title":"Oncoimmunology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2023.11.004","article-title":"Epidemiology and etiology of diffuse large B-cell lymphoma","volume":"60","author":"Wang","year":"2023","journal-title":"Semin Hematol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.mne.2018.10.006","article-title":"Fluorescence in situ hybridization (FISH): History, limitations and what to expect from micro-scale FISH","volume":"1","author":"Huber","year":"2018","journal-title":"Micro Nano Eng"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e582","DOI":"10.1097\/HS9.0000000000000582","article-title":"Biology of germinal center B cells relating to lymphomagenesis","volume":"5","author":"Basso","year":"2021","journal-title":"Hemasphere"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117568","article-title":"Next-Generation sequencing transforming clinical practice and precision medicine","volume":"551","author":"Yadav","year":"2023","journal-title":"Clin Chim Acta"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2015.10.017","article-title":"Clinical features and diagnosis of hairy cell leukemia","volume":"28","author":"Quest","year":"2015","journal-title":"Best Pract Res Clin Hematol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.5858\/2008-132-441-AOIITD","article-title":"Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma","volume":"132","author":"Higgins","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"B42","unstructured":"Advances in the diagnosis and Evaluation of Disabling Physical Health Conditions"},{"key":"B43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5045\/br.2022.2022037","article-title":"Basic immunohistochemistry for lymphoma diagnosis","volume":"57","author":"Cho","year":"2022","journal-title":"Blood Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21756","article-title":"The current role of clinical flow cytometry in the evaluation of mature B-cell neoplasms","volume":"96","author":"Seegmiller","year":"2019","journal-title":"Cytomet B Clin Cytom"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e31825d550a","article-title":"Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results","volume":"21","author":"Boyd","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1590\/S0482-50042010000500008","article-title":"Immune system - part II: basis of the immunological response mediated by T and B lymphocytes","volume":"50","author":"Mesquita J\u00fanior","year":"2010","journal-title":"Rev Bras Reumatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11080","article-title":"Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders","volume":"93","author":"Rawstron","year":"2008","journal-title":"Hematologica"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2006.06.012","article-title":"Immunophenotyping and differential diagnosis of hairy cell leukemia","volume":"20","author":"Matutes","year":"2006","journal-title":"Hematol Oncol Clin North Am"},{"key":"B49","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.cll.2017.07.001","article-title":"Flow cytometry of B-cell neoplasms","volume":"37","author":"Kroft","year":"2017","journal-title":"Clin Lab Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.pathol.2022.07.005","article-title":"A new approach to the study of Hodgkin lymphoma by flow cytometry","volume":"55","author":"Beatriz \u00c1lvarez Flores","year":"2023","journal-title":"Pathology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115369","article-title":"Primary mediastinal B-cell lymphoma (PMBCL): The LYSA pragmatic guidelines","volume":"220","author":"Renaud","year":"2025","journal-title":"Eur J Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21595","article-title":"Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonization project","volume":"94","author":"Rawstron","year":"2018","journal-title":"Cytomet B Clin Cytom"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"key":"B55","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11912-021-01094-y","article-title":"Leukemic variant of mantle cell lymphoma: clinical presentation and management","volume":"23","author":"Isaac","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2016-0521-RA","article-title":"Diagnostic algorithm of common mature B-cell lymphomas by immunohistochemistry","volume":"141","author":"Wang","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16356-3","article-title":"Simple diagnostic assay for hairy cell leukemia by immunocytochemical detection of annexin A1 (ANXA1)","volume":"363","author":"Falini","year":"2004","journal-title":"Lancet"},{"key":"B58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.blre.2014.06.003","article-title":"Hairy cell leukemia: Update on molecular profiling and therapeutic advances","volume":"28","author":"Grever","year":"2014","journal-title":"Blood Rev"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01078","article-title":"Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment","volume":"10","author":"Harjunp\u00e4\u00e4","year":"2019","journal-title":"Front Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-689422","article-title":"Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia","volume":"129","author":"Grever","year":"2017","journal-title":"Blood"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv200","article-title":"Hairy cell leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","author":"Robak","year":"2015","journal-title":"Ann Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"N Engl J Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16173054","article-title":"Rare clinical symptoms in hairy cell leukemia: an overview","volume":"16","author":"Robak","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e3003276","DOI":"10.1371\/journal.pbio.3003276","article-title":"TiME for a change: The tumor microenvironment as the missing piece in cancer therapeutics","volume":"23","author":"Mo","year":"2025","journal-title":"PloS Biol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"B66","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40164-022-00277-y","article-title":"Heterogeneity of the tumor immune microenvironment and its clinical relevance","volume":"11","author":"Jia","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15020501","article-title":"Shaping up the tumor microenvironment: extracellular vesicles as important intermediaries in building a tumor-supportive cellular network","volume":"15","author":"Sharma","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-024-00591-7","article-title":"Biomechanics in the tumor microenvironment: from biological functions to potential clinical applications","volume":"14","author":"Peng","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","article-title":"The clinical role of the TME in solid cancer","volume":"120","author":"Giraldo","year":"2019","journal-title":"Br J Cancer"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1407981","article-title":"Editorial: Tumor microenvironment and hematological Malignancies: new evidences and new questions","volume":"15","author":"Fiorcari","year":"2024","journal-title":"Front Immunol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.766275","article-title":"Deciphering tumor niches: lessons from solid and hematological Malignancies","volume":"12","author":"Mancini","year":"2021","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116117","article-title":"Biomechanical forces and force-triggered drug delivery in tumor neovascularization","volume":"171","author":"Wendong","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1548234","article-title":"Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies","volume":"16","author":"Nair","year":"2025","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061469","article-title":"Tumor immune microenvironment in lymphoma: focus on epigenetics","volume":"14","author":"Garc\u00eda-Dom\u00ednguez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092513","article-title":"The leading role of the immune microenvironment in multiple myeloma: A new target with a great prognostic and clinical value","volume":"11","author":"Desantis","year":"2022","journal-title":"J Clin Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-1971-z","article-title":"Live-animal imaging of native hematopoietic stem and progenitor cells","volume":"578","author":"Christodoulou","year":"2020","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/nature13034","article-title":"Direct measurement of local oxygen concentration in the bone marrow of live animals","volume":"508","author":"Spencer","year":"2014","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1331355","article-title":"Tumor response to hypoxia: understanding the hypoxic tumor microenvironment to improve treatment outcome in solid tumors","volume":"14","author":"Bigos","year":"2024","journal-title":"Front Oncol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.12.011","article-title":"Tumor hypoxia: From basic knowledge to therapeutic implications","volume":"88","author":"Liao","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15981","article-title":"The hypoxia signaling pathway in hematological Malignancies","volume":"8","author":"Irigoyen","year":"2017","journal-title":"Oncotarget"},{"key":"B81","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13046-022-02522-y","article-title":"Targeting hypoxia in solid and hematological Malignancies","volume":"41","author":"Harris","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2014.02.007","article-title":"Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond","volume":"41","author":"Mittal","year":"2014","journal-title":"Semin Oncol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1182\/asheducation-2011.1.1","article-title":"Angiogenesis: a target in solid tumors, also in leukemia","volume":"2011","author":"Schmidt","year":"2011","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"B84","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/152581602753448522","article-title":"A review of angiogenesis and anti-angiogenic therapy in hematologic Malignancies","volume":"11","author":"Rajkumar","year":"2002","journal-title":"J Hematother Stem Cell Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-0917","article-title":"Metabolic reprogramming in hematologic Malignancies: advances and clinical perspectives","volume":"82","author":"Yu","year":"2022","journal-title":"Cancer Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1077358","article-title":"Editorial: Linking cellular metabolism to hematological Malignancies","volume":"12","author":"He","year":"2022","journal-title":"Front Oncol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.195396","article-title":"Updates on the hematologic tumor microenvironment and its therapeutic targeting","volume":"104","author":"Forte","year":"2019","journal-title":"Hematologica"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.403","article-title":"The tumor microenvironment shapes hallmarks of mature B-cell Malignancies","volume":"34","author":"Shain","year":"2015","journal-title":"Oncogene"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.784691","article-title":"Bone marrow lymphoid niche adaptation to mature B cell neoplasms","volume":"12","author":"Dumontet","year":"2021","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.028035","article-title":"Niche contributions to oncogenesis: emerging concepts and implications for the hematopoietic system","volume":"96","author":"Raaijmakers","year":"2011","journal-title":"Hematologica"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2015.1068308","article-title":"CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates","volume":"57","author":"Hartmann","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041466","article-title":"Bone marrow stromal cells drive key hallmarks of B cell Malignancies","volume":"21","author":"Mangolini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s13046-022-02579-9","article-title":"Insights into the tumor microenvironment of B cell lymphoma","volume":"41","author":"Ng","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.06.012","article-title":"Cytokine and chemokine profiles in multiple myeloma; significance of stromal interaction and correlation of IL-8 production with disease progression","volume":"31","author":"Kline","year":"2007","journal-title":"Leuk Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020217","article-title":"Nurse-like cells and chronic lymphocytic leukemia B cells: A mutualistic crosstalk inside tissue microenvironments","volume":"10","author":"Fiorcari","year":"2021","journal-title":"Cells"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-737239","article-title":"IL-4\/CXCL12 loop is a key regulator of lymphoid stroma function in follicular lymphoma","volume":"129","author":"Pandey","year":"2017","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006169","article-title":"Nurselike cells sequester B cells in disorganized lymph nodes in chronic lymphocytic leukemia via alternative production of CCL21","volume":"6","author":"Zaaboub","year":"2022","journal-title":"Blood Adv"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112542","article-title":"Bone marrow mesenchymal stromal cells in multiple myeloma: their role as active contributors to myeloma progression","volume":"13","author":"Maiso","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2340","article-title":"Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other Malignant lymphoid cell lines","volume":"103","author":"Nefedova","year":"2004","journal-title":"Blood"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1038\/bcj.2012.17","article-title":"Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy","volume":"2","author":"Nwabo Kamdje","year":"2012","journal-title":"Blood Cancer J"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092089","article-title":"The bone marrow microenvironment in B-cell development and Malignancy","volume":"14","author":"Hughes","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3306","article-title":"ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile","volume":"101","author":"Wiestner","year":"2003","journal-title":"Blood"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in hematological Malignancies","volume":"20","author":"M\u00e9ndez-Ferrer","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.113852","article-title":"A hostel for the hostile: the bone marrow niche in hematologic neoplasms","volume":"100","author":"Krause","year":"2015","journal-title":"Hematologica"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062206","article-title":"VLA-4 expression and activation in B cell Malignancies: functional and clinical aspects","volume":"21","author":"H\u00e4rzschel","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-511527","article-title":"Reciprocal leukemia-stroma VCAM-1\/VLA-4-dependent activation of NF-\u03baB mediates chemoresistance","volume":"123","author":"Jacamo","year":"2014","journal-title":"Blood"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404621","article-title":"Bone marrow mesenchymal stem cells are abnormal in multiple myeloma","volume":"21","author":"Corre","year":"2007","journal-title":"Leukemia"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4940","article-title":"Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2","volume":"106","author":"Oshima","year":"2005","journal-title":"Blood"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208536","article-title":"Expression of EGF-family receptors and amphiregulin in multiple myeloma. Amphiregulin is a growth factor for myeloma cells","volume":"24","author":"Mahtouk","year":"2005","journal-title":"Oncogene"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05084.x","article-title":"Impaired osteoblastogenesis in myeloma bone disease: role of upregulated apoptosis by cytokines and Malignant plasma cells","volume":"126","author":"Silvestris","year":"2004","journal-title":"Br J Haematol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1369\/jhc.2008.952200","article-title":"Altered expression of fibronectin and collagens I and IV in multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"57","author":"Tancred","year":"2009","journal-title":"J Histochem Cytochem"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.102","article-title":"Proteomic characterization of human multiple myeloma bone marrow extracellular matrix","volume":"31","author":"Glavey","year":"2017","journal-title":"Leukemia"},{"key":"B113","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1182\/blood.V83.2.497.497","article-title":"The bone marrow fibrosis of hairy-cell leukemia is caused by the synthesis and assembly of a fibronectin matrix by the hairy cells","volume":"83","author":"Burthem","year":"1994","journal-title":"Blood"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1172\/JCI19540","article-title":"TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia","volume":"113","author":"Shehata","year":"2004","journal-title":"J Clin Invest"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1122699","article-title":"The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives","volume":"13","author":"Gargiulo","year":"2023","journal-title":"Front Oncol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.slasd.2023.03.006","article-title":"In Vitro three-dimensional (3D) cell culture tools for spheroid and organoid models","volume":"28","author":"Lee","year":"2023","journal-title":"SLAS Discov"},{"key":"B117","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12929-024-00994-y","article-title":"Scaffold-based 3D cell culture models in cancer research","volume":"31","author":"Abuwatfa","year":"2024","journal-title":"J BioMed Sci"},{"key":"B118","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-98094-2_16","article-title":"Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis","volume-title":"Ovarian Cancer","author":"Kenny","year":"2009"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103511","article-title":"Molecular insights of metastasis and cancer progression derived using 3D cancer spheroid co-culture in vitro platform","volume":"168","author":"Modi","year":"2021","journal-title":"Crit Rev Oncology\/Hematol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.607608","article-title":"Modeling the leukemia microenvironment in vitro","volume":"10","author":"Scielzo","year":"2020","journal-title":"Front Oncol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"e932","DOI":"10.1097\/HS9.0000000000000932","article-title":"Emerging strategies in 3D culture models for hematological cancers","volume":"7","author":"Barozzi","year":"2023","journal-title":"HemaSphere"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/cells14010038","article-title":"In vitro 3D models of hematological Malignancies: current trends and the road ahead","volume":"14","author":"Mattioda","year":"2025","journal-title":"Cells"},{"key":"B123","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s40824-023-00457-9","article-title":"Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system","volume":"27","author":"Alhattab","year":"2023","journal-title":"Biomater Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.248112","article-title":"Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents","volume":"106","author":"Barbaglio","year":"2020","journal-title":"hematol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2025.101105","article-title":"Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro","volume":"5","author":"Barozzi","year":"2025","journal-title":"Cell Rep Methods"},{"key":"B126","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1089\/ten.TEC.2023.0374","article-title":"Liquid overlay and collagen-based three-dimensional models for in vitro investigation of multiple myeloma","volume":"30","author":"Ilic","year":"2024","journal-title":"Tissue Eng Part C Methods"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S503984","article-title":"A high-throughput, three-dimensional multiple myeloma model recapitulating tumor-stroma interactions for CAR-immune cell-mediated cytotoxicity assay","volume":"14","author":"Luanpitpong","year":"2025","journal-title":"Immunotargets Ther"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.605231","article-title":"Developing a 3D B cell lymphoma culture system to model antibody therapy","volume":"11","author":"Foxall","year":"2021","journal-title":"Front Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.947823","article-title":"A bone-based 3D scaffold as an in-vitro model of microenvironment\u2013DLBCL lymphoma cell interaction","volume":"12","author":"Ceccato","year":"2022","journal-title":"Front Oncol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e2100884","DOI":"10.1002\/adhm.202100884","article-title":"A 3D-bioprinted multiple myeloma model","volume":"11","author":"Wu","year":"2022","journal-title":"Adv Healthc Mater"},{"key":"B131","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-7021-6_13","article-title":"3D-dynamic culture models of multiple myeloma","volume-title":"3D Cell Culture. Methods in Molecular Biology","author":"Ferrarini","year":"2017"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12643","article-title":"A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications","volume":"7","author":"Jakubikova","year":"2016","journal-title":"Oncotarget"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2023-184","article-title":"Abstract 184: Multiple Myeloma 3D model: A platform for testing drug effects on myeloma in conjunction with the bone marrow niche","volume":"83","author":"Rashad","year":"2023","journal-title":"Cancer Res"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e70199","DOI":"10.1002\/hem3.70199","article-title":"3D Tumor microenvironment interaction reveals AP-1 complex regulation and contact-mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia","volume":"9","author":"Lindacher","year":"2025","journal-title":"Hemasphere"},{"key":"B135","doi-asserted-by":"publisher","first-page":"e938","DOI":"10.1097\/HS9.0000000000000938","article-title":"In vitro 3D spheroid culture system displays sustained T cell-dependent CLL proliferation and survival","volume":"7","author":"Haselager","year":"2023","journal-title":"Hemasphere"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.101544","article-title":"Lymphoma-on-chip model reveals that lymph node stromal cells promote diffuse large B-cell lymphoma survival and migration","volume":"31","author":"Jouybar","year":"2025","journal-title":"Mater Today Bio"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S363994","article-title":"Development and characterization of 3D hybrid spheroids for the investigation of the crosstalk between B-cell non-hodgkin lymphomas and mesenchymal stromal cells","volume":"15","author":"Du\u015b-Szachniewicz","year":"2022","journal-title":"Onco Targets Ther"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1606573","article-title":"Harnessing 3D cell models and high-resolution imaging to unveil the mechanisms of nanoparticle-mediated drug delivery","volume":"13","author":"Chalkley","year":"2025","journal-title":"Front Bioeng Biotechnol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s10529-024-03465-4","article-title":"Dynamic cultivation of human mesenchymal stem\/stromal cells for the production of extracellular vesicles in a 3D bioreactor system","volume":"46","author":"Almeria","year":"2024","journal-title":"Biotechnol Lett"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1967.tb08741.x","article-title":"The nature and significance of platelet products in human plasma","volume":"13","author":"Wolf","year":"1967","journal-title":"Br J Haematol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1317-6","article-title":"Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation","volume":"38","author":"Ciardiello","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-020-00466-1","article-title":"Isolation and characterization of extracellular vesicle subpopulations from tissues","volume":"16","author":"Crescitelli","year":"2021","journal-title":"Nat Protoc"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3791\/67699","article-title":"Characterizing extracellular vesicles from biological fluids","volume":"196","author":"Hefley","year":"2025","journal-title":"J Vis Exp"},{"key":"B144","doi-asserted-by":"publisher","first-page":"10878","DOI":"10.1038\/s41467-024-55231-9","article-title":"Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia","volume":"15","author":"Forte","year":"2024","journal-title":"Nat Commun"},{"key":"B145","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s12967-025-06522-2","article-title":"Diagnostic and prognostic roles of endothelial- and platelet-derived extracellular vesicles in cardiovascular diseases","volume":"23","author":"Di Febo","year":"2025","journal-title":"J Transl Med"},{"key":"B146","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2014.05.004","article-title":"Biogenesis and secretion of exosomes","volume":"29","author":"Kowal","year":"2014","journal-title":"Curr Opin Cell Biol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1096\/fba.2020-00127","article-title":"The ins and outs of microvesicles","volume":"3","author":"Clancy","year":"2021","journal-title":"FASEB Bioadv"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3390\/biology9010021","article-title":"Apoptotic bodies: particular extracellular vesicles involved in intercellular communication","volume":"9","author":"Battistelli","year":"2020","journal-title":"Biol (Basel)"},{"key":"B150","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12964-019-0401-z","article-title":"A novel population of extracellular vesicles smaller than exosomes promotes cell proliferation","volume":"17","author":"Lee","year":"2019","journal-title":"Cell Commun Signal"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2025.04.012","article-title":"Exomeres and supermeres: Current advances and perspectives","volume":"50","author":"Yu","year":"2025","journal-title":"Bioact Mater"},{"key":"B152","article-title":"Observations on cell lines derived from a patient with Hodgkin\u2019s disease","volume":"38","author":"Friend","year":"1978","journal-title":"Cancer Res"},{"key":"B153","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ijc.2910230112","article-title":"Rigid plasma-membrane-derived vesicles, enriched in tumor-associated surface antigens (MLr), occurring in the ascites fluid of a murine leukemia (GRSL)","volume":"23","author":"van Blitterswijk","year":"1979","journal-title":"Int J Cancer"},{"key":"B154","doi-asserted-by":"publisher","first-page":"e1376153","DOI":"10.1080\/2162402X.2017.1376153","article-title":"Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy","volume":"7","author":"K\u00f6nig","year":"2017","journal-title":"Oncoimmunology"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10121065","article-title":"Extracellular vesicles in hematological Malignancies: from biomarkers to therapeutic tools","volume":"10","author":"Khalife","year":"2020","journal-title":"Diagn (Basel)"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/medsci12010004","article-title":"Extracellular vesicles\u2019 Role in angiogenesis and altering angiogenic signaling","volume":"12","author":"Ateeq","year":"2024","journal-title":"Med Sci (Basel)"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-023-10147-6","article-title":"Tissue-derived extracellular vesicles in cancer progression: mechanisms, roles, and potential applications","volume":"43","author":"Ye","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02282-1","article-title":"Extracellular vesicles in cancer\u00b4s communication: messages we can read and how to answer","volume":"24","author":"Semeradtova","year":"2025","journal-title":"Mol Cancer"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1084\/jem.183.3.1161","article-title":"B lymphocytes secrete antigen-presenting vesicles","volume":"183","author":"Raposo","year":"1996","journal-title":"J Exp Med"},{"key":"B160","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-025-02233-w","article-title":"Extracellular vesicles in tumor immunity: mechanisms and novel insights","volume":"24","author":"Kuang","year":"2025","journal-title":"Mol Cancer"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6272498","article-title":"Tumor-derived exosomes in immunosuppression and immunotherapy","volume":"2020","author":"Olejarz","year":"2020","journal-title":"J Immunol Res"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1002\/path.4306","article-title":"Protrusion-guided extracellular vesicles mediate CD30 trans-signaling in the microenvironment of Hodgkin\u2019s lymphoma","volume":"232","author":"Hansen","year":"2014","journal-title":"J Pathol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines4030022","article-title":"The IL-8\/IL-8R axis: A double agent in tumor immune resistance","volume":"4","author":"David","year":"2016","journal-title":"Vaccines"},{"key":"B164","doi-asserted-by":"publisher","first-page":"e1421889","DOI":"10.1080\/2162402X.2017.1421889","article-title":"Specific ADAM10 inhibitors localize in exosome-like vesicles released by Hodgkin lymphoma and stromal cells and prevent sheddase activity carried to bystander cells","volume":"7","author":"Tosetti","year":"2018","journal-title":"Oncoimmunology"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-805499","article-title":"Extracellular vesicle\u2013mediated transfer of constitutively active MyD88L265P engages MyD88wt and activates signaling","volume":"131","author":"Man\u010dek-Keber","year":"2018","journal-title":"Blood"},{"key":"B166","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1038\/bcj.2017.72","article-title":"From Waldenstr\u00f6m\u2019s macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation","volume":"7","author":"Jim\u00e9nez","year":"2017","journal-title":"Blood Cancer J"},{"key":"B167","doi-asserted-by":"publisher","first-page":"e12841","DOI":"10.1111\/sji.12841","article-title":"Diffuse large B cell lymphoma-derived extracellular vesicles educate macrophages to promote tumors progression by increasing PGC-1\u03b2","volume":"91","author":"Liu","year":"2020","journal-title":"Scand J Immunol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S203010","article-title":"NSE from diffuse large B-cell lymphoma cells regulates macrophage polarization","volume":"11","author":"Zhu","year":"2019","journal-title":"CMAR"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.91154","article-title":"Tumor-derived exosomal ENO2 modulates polarization of tumor-associated macrophages through reprogramming glycolysis to promote progression of diffuse large B-cell lymphoma","volume":"20","author":"Shao","year":"2024","journal-title":"Int J Biol Sci"},{"key":"B170","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13046-020-01747-z","article-title":"MiR-7e-5p downregulation promotes transformation of low-grade follicular lymphoma to aggressive lymphoma by modulating an immunosuppressive stroma through the upregulation of FasL in M1 macrophages","volume":"39","author":"Lou","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B171","doi-asserted-by":"publisher","first-page":"40","DOI":"10.22074\/cellj.2020.6550","article-title":"Effect of plasma-derived exosomes of refractory\/relapsed or responsive patients with diffuse large B-cell lymphoma on natural killer cells functions","volume":"22","author":"Zare","year":"2020","journal-title":"Cell J"},{"key":"B172","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13046-018-0863-7","article-title":"Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo","volume":"37","author":"Chen","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2956","article-title":"Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B-cell lymphoma","volume":"40","author":"Cao","year":"2022","journal-title":"Hematol Oncol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1111\/febs.70093","article-title":"Extracellular vesicles in multiple myeloma: pathogenesis and therapeutic application","volume":"292","author":"Wylie","year":"2025","journal-title":"FEBS J"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113185","article-title":"Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression","volume":"10","author":"Saltarella","year":"2021","journal-title":"Cells"},{"key":"B176","doi-asserted-by":"publisher","first-page":"e1279372","DOI":"10.1080\/2162402X.2017.1279372","article-title":"Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70\/TLR2\/NF-kB axis","volume":"6","author":"Vulpis","year":"2017","journal-title":"Oncoimmunology"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112865","article-title":"Multiple myeloma cell-derived exosomes: implications on tumorigenesis, diagnosis, prognosis and therapeutic strategies","volume":"10","author":"Allegra","year":"2021","journal-title":"Cells"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1265101","article-title":"Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma","volume":"14","author":"Matchett","year":"2023","journal-title":"Front Immunol"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.7150\/jca.55553","article-title":"Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosis","volume":"12","author":"Lee","year":"2021","journal-title":"J Cancer"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1640168","article-title":"Bone marrow-derived extracellular vesicles from multiple myeloma patients promote adaptive immune dysfunction via HLA-G, PD-1, and PD-L1","volume":"16","author":"Soncini","year":"2025","journal-title":"Front Immunol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1111\/cas.70099","article-title":"Immunosuppressive effects of multiple myeloma-derived extracellular vesicles through T cell exhaustion","volume":"116","author":"Hagiwara","year":"2025","journal-title":"Cancer Sci"},{"key":"B182","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3892\/ol.2020.11892","article-title":"Involvement of MM cell-derived exosomes in T lymphocytes immune responses","volume":"20","author":"Shao","year":"2020","journal-title":"Oncol Lett"},{"key":"B183","doi-asserted-by":"publisher","first-page":"e1458809","DOI":"10.1080\/2162402X.2018.1458809","article-title":"Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD","volume":"7","author":"Morandi","year":"2018","journal-title":"Oncoimmunology"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6083","article-title":"The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11121240","article-title":"miR-335-laden B cell-derived extracellular vesicles promote SOX4-dependent apoptosis in human multiple myeloma cells","volume":"11","author":"Lombardi","year":"2021","journal-title":"J Pers Med"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.217","article-title":"Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression","volume":"31","author":"Boysen","year":"2017","journal-title":"Leukemia"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-618470","article-title":"Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling","volume":"125","author":"Yeh","year":"2015","journal-title":"Blood"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1243790","article-title":"Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia","volume":"58","author":"De Luca","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-09-242719","article-title":"Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression","volume":"115","author":"Ghosh","year":"2010","journal-title":"Blood"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3741-3","article-title":"High serum levels of extracellular vesicles expressing Malignancy-related markers are released in patients with various types of hematological neoplastic disorders","volume":"36","author":"Caivano","year":"2015","journal-title":"Tumor Biol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-618025","article-title":"Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts","volume":"126","author":"Paggetti","year":"2015","journal-title":"Blood"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2015.329","article-title":"Stamping out RAF and MEK1\/2 to inhibit the ERK1\/2 pathway: an emerging threat to anticancer therapy","volume":"35","author":"Mandal","year":"2016","journal-title":"Oncogene"},{"key":"B193","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.cell.2017.06.031","article-title":"Exosome RNA unshielding couples stromal activation to pattern recognition receptor signaling in cancer","volume":"170","author":"Nabet","year":"2017","journal-title":"Cell"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-682377","article-title":"Extracellular vesicles released by CD40\/IL-4-stimulated CLL cells confer altered functional properties to CD4+ T cells","volume":"128","author":"Smallwood","year":"2016","journal-title":"Blood"},{"key":"B195","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1158\/2643-3230.BCD-22-0029","article-title":"Extracellular vesicle secretion by leukemia cells in vivo promotes CLL progression by hampering antitumor T-cell responses","volume":"4","author":"Gargiulo","year":"2023","journal-title":"Blood Cancer Discov"},{"key":"B196","doi-asserted-by":"publisher","first-page":"e16899","DOI":"10.1371\/journal.pone.0016899","article-title":"Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia\/lymphoma T and B cells","volume":"6","author":"Hedlund","year":"2011","journal-title":"PloS One"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02590-x","article-title":"CLL cell-derived exosomes alter the immune and hematopoietic systems","volume":"39","author":"Veletic","year":"2025","journal-title":"Leukemia"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-024-00802-7","article-title":"Extracellular vesicles from type-2 macrophages increase the survival of chronic lymphocytic leukemia cells ex vivo","volume":"31","author":"Ikhlef","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"B199","doi-asserted-by":"publisher","first-page":"e70068","DOI":"10.1002\/hem3.70068","article-title":"Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into nurse-like cells via an RNA-dependent mechanism","volume":"9","author":"Dubois","year":"2025","journal-title":"Hemasphere"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5b08015","article-title":"Evidence-based clinical use of nanoscale extracellular vesicles in nanomedicine","volume":"10","author":"Fais","year":"2016","journal-title":"ACS Nano"},{"key":"B201","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1038\/ncomms7365","article-title":"Substrate stress relaxation regulates cell spreading","volume":"6","author":"Chaudhuri","year":"2015","journal-title":"Nat Commun"},{"key":"B202","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/j.bbamcr.2017.05.027","article-title":"Metalloproteinases in extracellular vesicles","volume":"1864","author":"Shimoda","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"B203","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/bs.acc.2018.10.006","article-title":"Extracellular vesicle-associated MMPs: A modulator of the tissue microenvironment","volume":"88","author":"Shimoda","year":"2019","journal-title":"Adv Clin Chem"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.3390\/cells7120236","article-title":"Heparanase: A multitasking protein involved in extracellular matrix (ECM) remodeling and intracellular events","volume":"7","author":"Masola","year":"2018","journal-title":"Cells"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1725066","article-title":"Biology of the heparanase-heparan sulfate axis and its role in disease pathogenesis","volume":"47","author":"Vlodavsky","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"B206","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1002\/pgr2.1","article-title":"Extracellular vesicles released during hypoxia transport heparanase and enhance macrophage migration, endothelial tube formation and cancer cell stemness","volume":"1","author":"Tripathi","year":"2023","journal-title":"Proteoglycan Res"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.686295","article-title":"Fibronectin on the surface of myeloma cell-derived exosomes mediates exosome-cell interactions","volume":"291","author":"Purushothaman","year":"2016","journal-title":"J Biol Chem"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2025.2562951","article-title":"The tumor microenvironment in hairy cell leukemia (HCL) and splenic B cell lymphoma with prominent nucleoli (SBLPN)","volume":"67","author":"Watrin","year":"2025","journal-title":"Leukemia Lymphoma"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.9.3161","article-title":"Involvement of CD44-hyaluronan interaction in Malignant cell homing and fibronectin synthesis in hairy cell leukemia","volume":"96","author":"Aziz","year":"2000","journal-title":"Blood"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3737","article-title":"The role of autocrine FGF-2 in the distinctive bone marrow fibrosis of hairy-cell leukemia (HCL)","volume":"102","author":"Aziz","year":"2003","journal-title":"Blood"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.3.1077.415k06_1077_1085","article-title":"Basic fibroblast growth factor is expressed by CD19\/CD11c-positive cells in hairy cell leukemia","volume":"94","author":"Gruber","year":"1999","journal-title":"Blood"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.37349\/ei.2025.1003211","article-title":"Macrophages and fibroblasts in cardiac fibrosis: interactions and transformation","volume":"5","author":"Kim","year":"2025","journal-title":"Explor Immunol"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03151-0","article-title":"Basic principles of biobanking: from biological samples to precision medicine for patients","volume":"479","author":"Annaratone","year":"2021","journal-title":"Virchows Arch"},{"key":"B214","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11926-025-01189-6","article-title":"Biorepositories for global rare disease research: A narrative review","volume":"27","author":"Pellico","year":"2025","journal-title":"Curr Rheumatol Rep"},{"key":"B215","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13023-018-0942-z","article-title":"Impact of biobanks on research outcomes in rare diseases: a systematic review","volume":"13","author":"Garcia","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B216","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1002\/jex2.76","article-title":"Standardizing the preanalytical reporting of biospecimens to improve reproducibility in extracellular vesicle research - A GEIVEX study","volume":"2","author":"L\u00f3pez-Guerrero","year":"2023","journal-title":"J Extracell Biol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.309417","article-title":"Methodological guidelines to study extracellular vesicles","volume":"120","author":"Coumans","year":"2017","journal-title":"Circ Res"},{"key":"B218","doi-asserted-by":"publisher","first-page":"e12385","DOI":"10.1002\/jev2.12385","article-title":"MIBlood-EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research","volume":"12","author":"Lucien","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"B219","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1160\/TH10-09-0595","article-title":"Pre-analytical and analytical issues in the analysis of blood microparticles","volume":"105","author":"Yuana","year":"2011","journal-title":"Thromb Hemost"},{"key":"B220","first-page":"175","article-title":"Standardization and reproducibility in EV research: the support of a Quality Management System","volume-title":"Advances in biomembranes and lipid self-assembly","author":"Liguori","year":"2021"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.580874","article-title":"Diagnostic and therapeutic potential of extracellular vesicles in B-cell Malignancies","volume":"10","author":"Gargiulo","year":"2020","journal-title":"Front Oncol"},{"key":"B222","doi-asserted-by":"publisher","first-page":"e12510","DOI":"10.1002\/jev2.12510","article-title":"A critical systematic review of extracellular vesicle clinical trials","volume":"13","author":"Mizenko","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1265969","article-title":"Extracellular vesicles in hematological Malignancies: EV-dence for reshaping the tumoral microenvironment","volume":"14","author":"Van Morckhoven","year":"2023","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1741794\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:33:17Z","timestamp":1771392797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1741794\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":223,"alternative-id":["10.3389\/fimmu.2026.1741794"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1741794","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"article-number":"1741794"}}